A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/2009
12/08/2009	CA2440744C Il-12 expression controlling agent
12/08/2009	CA2434911C Use of l-carnitine as stabilizing agent of proteins
12/08/2009	CA2419301C Quinazoline derivatives
12/08/2009	CA2415486C Pyramidine derivatives
12/08/2009	CA2398794C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
12/08/2009	CA2369979C 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors
12/08/2009	CA2355075C Heteroaryl-cyclic acetals
12/03/2009	WO2009146255A1 Prostaglandin produgs as hypotensive agents
12/03/2009	WO2009145238A1 Immunomodulatory agent and use thereof
12/03/2009	WO2009143572A1 Methods of treating mammals with eustachian tube dysfunctions
12/03/2009	WO2009114878A3 Methods and compositions for genetic and retinal disease
12/03/2009	WO2009114623A3 Angiostatic compositions comprising truncated tyrosyl-trna synthetase polypeptides and methods of using same
12/03/2009	WO2009048539A3 Use of anti-amyloid beta antibody in ocular diseases
12/03/2009	WO2009024677A3 Use of hyaluronic acid for preparing compositions for improving the function of skin, eye and mucous membrane protection
12/03/2009	US20090298899 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); {3-[(4-Chloro-biphenyl-3-carbonyl)-amino]-phenyl}-acetic acid; glaucoma or ocular hypertension; dysmenorrhoea, preterm labour, immune disorders, inflammatory disorders
12/03/2009	US20090298839 Adrb2 gene polymorphism associated with intraocular pressure response to topical beta-blockers
12/03/2009	US20090297538 Neurotoxic oligomers
12/03/2009	US20090297533 Controlled release immunomodulator compositions and methods for the treatment of otic disorders
12/03/2009	CA2765190A1 Methods of treating mammals with eustachian tube dysfunctions
12/03/2009	CA2724605A1 Prostaglandin prodrugs as hypotensive agents
12/02/2009	EP2128248A1 Oligonucleotide compositions with enhanced efficiency
12/02/2009	EP2128156A1 Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibiting activity
12/02/2009	EP2128134A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13
12/02/2009	EP2127658A1 Therapeutic agent for meniere s disease
12/02/2009	EP2127655A1 Use of loteprednol etabonate for the treatment of dry eye
12/02/2009	EP2126092A2 Fusion proteins binding to growth factors
12/02/2009	EP2125773A1 Thiophene derivatives useful as medicaments for treating ocular hypertension
12/02/2009	EP2124973A1 Use of a masked or coated copper salt for the treatment of macular degeneration
12/02/2009	EP1666043B1 Product containing prostaglandin
12/02/2009	EP1542984B1 Methods of purifying cannabinoids from plant material
12/02/2009	EP1349841B1 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
12/02/2009	EP1248804B2 Recombinant antibodies to human interleukin-1 beta
12/02/2009	CN101595106A Substituted gamma lactams as therapeutic agents
12/02/2009	CN101591655A PKCalpha signal specifically-blocking siRNA and use thereof
12/02/2009	CN101590149A Traditional Chinese medicine composition with function of relieving asthenopia and preparation method thereof
12/02/2009	CN101590143A External ointment formulation for treating blepharitis marginalis and preparation process thereof
12/02/2009	CN101590083A Yinxingdamo oral preparation equivalent to similar intravenous preparation
12/02/2009	CN101590080A Chinese medicament for curing purulent ear
12/02/2009	CN101590067A Tympanitis compound preparation suitable for dogs
12/02/2009	CN101590015A Cationic adhesion type mycophenolate mofetil nano eye drop
12/02/2009	CN100564375C (3Z) -3-(2,3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
12/02/2009	CN100564351C Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it
12/02/2009	CN100563657C Enoxacin ocular sustained release gelata and preparation thereof
12/02/2009	CN100563642C Chloromycetin eyedrops and preparation method thereof
12/02/2009	CN100563628C Bendalysine eye gel preparation and its making method
12/01/2009	US7625937 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators
12/01/2009	US7625934 Metalloproteinase inhibitors
12/01/2009	US7625929 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
12/01/2009	US7625892 Pharmaceutical compositions for the treatment of diseases related to neurotrophines
12/01/2009	US7625883 Choline Salt of L- alpha -glycero-phospho-D-mio-inositol; alpha -glycero-phospho-D-mio-inositol tetrabutylammonium salt; treatment of pathologies mediated by the activation or over stimulation of cytololilc phospholipase-2 (PLA2), particularly, septic shock and viral and bacterial infections
12/01/2009	US7625713 Process for identifying a ligand that binds to the NEP binding site for the SMR1 pentapeptide
12/01/2009	US7625582 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
12/01/2009	CA2461100C 4-imidazolin-2-one compounds
12/01/2009	CA2432121C Nitric oxide synthase inhibitor phosphate salt
12/01/2009	CA2384718C Prostaglandin derivatives
11/2009
11/26/2009	WO2009142967A1 Therapeutic prostaglandin compounds used as ocular hypotensive agents
11/26/2009	WO2009142321A1 Novel thiophenediamine derivative having urea structure
11/26/2009	WO2009140863A1 Compositions comprising quinazoline derivatives, preparation methods and uses thereof
11/26/2009	WO2009120300A3 Method of treating degenerative diseases
11/26/2009	WO2009085277A3 Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars
11/26/2009	US20090292000 Pyrrolidine derivatives as prostaglandin modulators
11/26/2009	US20090291950 Bicyclic heteroaryl inhibitors of pde4
11/26/2009	US20090291917 Boron-Containing Small Molecules as Anti-Inflammatory Agents
11/26/2009	US20090291143 Combination of Azelastine and Steroids
11/26/2009	US20090291073 Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
11/26/2009	CA2724474A1 Therapeutic prostaglandin compounds used as ocular hypotensive agents
11/26/2009	CA2724357A1 Novel thiophenediamine derivative having urea structure
11/25/2009	EP2123306A1 Use of a decoy protein that interferes with the hedgehog signalling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovascularization
11/25/2009	EP2123303A1 Ameliorating agent for insulin resistance
11/25/2009	EP2123268A1 Pharmaceutical composition for prevention or treatment of disease associated with tear reduction
11/25/2009	EP2123264A1 Heterocyclic derivatives as abnormal cannabidiols agents for lowering intraocular pressure
11/25/2009	EP2121672A2 Substituted gamma lactams as therapeutic agents
11/25/2009	EP2120926A1 Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
11/25/2009	EP2120908A1 Solvating system and sealant for medical use
11/25/2009	EP1482932B1 N3 alkylated benzimidazole derivatives as mek inhibitors
11/25/2009	EP1242385B1 Cytokine, especially tnf-alpha, inhibitors
11/25/2009	EP1210108B1 Use of leptin together with an inhibitor of vegf and/or an inhibitor of angiogenesis for the inhibition of endothelial cell proliferation
11/25/2009	CN101589063A Humanized anti-factor D antibodies and uses thereof
11/25/2009	CN101585813A Prepartion method of N-acetyl-L-carnosine
11/25/2009	CN101584857A Ophthalmic preparation and preparation method thereof
11/25/2009	CN101584856A Medicament of treating ophthalmic disease
11/25/2009	CN101584791A Traditional chinese medicine for curing adolescent myopia
11/25/2009	CN101584769A Novel use of esculin and digitalisglycosides eye drops
11/25/2009	CN101584689A Compound eardrops containing antipyrine and lidocaine the and preparation method thereof
11/25/2009	CN100562340C A micro-emulsion type artificial tear
11/24/2009	US7622480 Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents
11/24/2009	US7622450 Flavone C-glycoside derivatives and compositions containing the derivatives
11/24/2009	US7622297 Administering a polynucleotide encoding a Mycrobacterium kansasii-derived alpha antigen; asthma, atopic dermatitis, allergic rhinitis, allergic conjunctivitis
11/24/2009	CA2507375C Use of rimexolone in the treatment of dry eye
11/24/2009	CA2475712C Nicotinamide derivatives useful as pde4 inhibitors
11/24/2009	CA2421504C 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
11/24/2009	CA2408144C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/24/2009	CA2383499C Drug delivery device
11/24/2009	CA2279427C Use of low dose photodynamic therapy for reducing the effects of inflammation
11/19/2009	WO2009140204A2 Selective subtype alpha 2 adrenergic agents and methods for use thereof
11/19/2009	WO2009140201A1 Methods for preventing the development of retinopathy by the oral administration of nnr ligands
11/19/2009	WO2009140138A1 Quinolynylmethylimidizoles as therapeutic agents
11/19/2009	WO2009139924A2 Controlled release corticosteroid compositions and methods for the treatment of otic disorders
11/19/2009	WO2009139464A1 Pharmaceutical composition for treatment of dry eye and/or corneal/conjunctival disorders
11/19/2009	WO2009139361A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group

1 ... 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 ... 531